Disease · HP_0100607
Trials45
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 2 more are not shown, since the checks do not confirm them.
1 to 20 of 45
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00909857 | Effect on Primary Dysmenorrhea | Phase 3 | 507 | 2012-02-27 | Primary Dysmenorrhea | DIENOGEST, ESTRADIOL VALERATE, ETHINYL ESTRADIOL, LEVONORGESTREL | Open Targets' reading of its record | ClinicalTrials.gov |
| NCT01670656 | A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057) | Phase 2 | 439 | 2017-08-24 | Dysmenorrhea | ETONOGESTREL, NOMEGESTROL ACETATE | Its record names the disease | ClinicalTrials.gov |
| NCT00461305 | Safety Study of Ethinylestradiol/Drospirenone in Dysmenorrhea | Phase 2/3 | 420 | 2010-10-01 | Dysmenorrhea | DROSPIRENONE, ETHINYL ESTRADIOL | Its record names the disease | ClinicalTrials.gov |
| NCT00511797 | SH T00186 Phase II/ III Optimal Drospirenone (DRSP) Dose Finding and Placebo-controlled Comparative Study | Phase 2/3 | 249 | 2010-10-04 | Dysmenorrhea | DROSPIRENONE | Its record names the disease | ClinicalTrials.gov |
| NCT01129102 | Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea | Phase 3 | 215 | 2014-06-17 | Dysmenorrhea | ETHINYL ESTRADIOL, NORETHINDRONE | Its record names the disease | ClinicalTrials.gov |
| NCT00902746 | Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis | Phase 3 | 149 | 2014-06-13 | Dysmenorrhea | ETHINYL ESTRADIOL, NORETHINDRONE | Its record names the disease | ClinicalTrials.gov |
| NCT00951561 | A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen | Not applicable | 115 | 2010-10-04 | Dysmenorrhea | IBUPROFEN | Its record names the disease | ClinicalTrials.gov |
| NCT00984815 | Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment | Phase 3 | 86 | 2013-07-25 | Osteoarthritis, Rheumatoid Arthritis, Chronic Low Back Pain, Chronic Regional Pain Syndrome, Chronic Soft Tissue Pain | FAMOTIDINE, IBUPROFEN | Its record names the disease | ClinicalTrials.gov |
| NCT00651313 | Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods) | Phase 2 | 81 | 2011-07-06 | Dysmenorrhea | LIDOCAINE | Its record names the disease | ClinicalTrials.gov |
| NCT00517556 | Continuous Administration of Oral Contraceptive, Primary Dysmenorrhea | Phase 1/2 | 38 | 2017-04-28 | Dysmenorrhea | ETHINYL ESTRADIOL | Its record names the disease | ClinicalTrials.gov |
| NCT03697720 | Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain | Phase 4 | 26 | 2023-10-18 | Dysmenorrhea, Pain | NAPROXEN | Its record names the disease | ClinicalTrials.gov |
| NCT02668783 | Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059) | Phase 3 | 25 | 2017-11-14 | Moderate to Severe Primary Dysmenorrhea | ESTRADIOL, ETONOGESTREL | Its record names the disease | ClinicalTrials.gov |
| NCT02668822 | Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060) | Phase 3 | 18 | 2017-11-08 | Dysmenorrhea | ESTRADIOL, ETONOGESTREL | Its record names the disease | ClinicalTrials.gov |
| NCT01375998 | YAZ Post-marketing Surveillance in Japan | 3,273 | Dysmenorrhea | DROSPIRENONE, ETHINYL ESTRADIOL | Its record names the disease | ClinicalTrials.gov | ||
| NCT04333576 | Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain | Phase 3 | 800 | Endometriosis | ELAGOLIX | Its record names the disease | ClinicalTrials.gov | |
| NCT03126747 | Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea | 715 | Endometriosis and Dysmenorrhea | ETHINYL ESTRADIOL | Its record names the disease | ClinicalTrials.gov | ||
| NCT02475356 | Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea | 601 | Menorrhagia, Dysmenorrhea | LEVONORGESTREL | Its record names the disease | ClinicalTrials.gov | ||
| NCT06861920 | NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL) | Phase 4 | 600 | Dysmenorrhea, Chronic Pelvic Pain, Pelvic Pain | ACETAMINOPHEN, NAPROXEN SODIUM | Its record names the disease | ClinicalTrials.gov | |
| NCT00329355 | Menstrual Migraine Treatment With TREXIMET (Formerly Known as TREXIMA) | Phase 3 | 351 | Migraine, Migraine Disorders | NAPROXEN SODIUM, SUMATRIPTAN SUCCINATE | Its record names the disease | ClinicalTrials.gov | |
| NCT02183025 | Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea | Phase 2 | 337 | Dysmenorrhea | MEFENAMIC ACID, MELOXICAM | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0100607/trials